Epand RM et al. |
Lipid-mediated a-factor interactions with artificial membranes. |
1995 |
Meth. Enzymol. |
pmid:7651149
|
Meigs TE et al. |
Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo. |
1996 |
J. Biol. Chem. |
pmid:8626470
|
Tachibana A et al. |
Evidence for farnesol-mediated isoprenoid synthesis regulation in a halophilic archaeon, Haloferax volcanii. |
1996 |
FEBS Lett. |
pmid:8566226
|
Satoh T et al. |
The effects of pravastatin, an HMG-CoA reductase inhibitor, on cell viability and DNA production of rat hepatocytes. |
1996 |
Life Sci. |
pmid:8831797
|
Tanaka H et al. |
MEKA/phosducin attenuates hydrophobicity of transducin beta gamma subunits without binding to farnesyl moiety. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8687440
|
Nishio E et al. |
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor impairs cell p4fferentiation in cultured adipogenic cells (3T3-L1). |
1996 |
Eur. J. Pharmacol. |
pmid:8773465
|
Carel K et al. |
Insulin stimulates mitogen-activated protein kinase by a Ras-independent pathway in 3T3-L1 adipocytes. |
1996 |
J. Biol. Chem. |
pmid:8940037
|
Tisch D et al. |
Activation of signaling pathways in HL60 cells and human neutrophils by farnesylthiosalicylate. |
1996 |
Eur. J. Biochem. |
pmid:9022678
|
McGuire TF et al. |
Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation. |
1996 |
J. Biol. Chem. |
pmid:8910319
|
Miquel K et al. |
Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8780704
|
Keller RK et al. |
Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver. |
1996 |
Arch. Biochem. Biophys. |
pmid:8645011
|
Koyama T et al. |
Identification of significant residues in the substrate binding site of Bacillus stearothermophilus farnesyl diphosphate synthase. |
1996 |
Biochemistry |
pmid:8755734
|
Umetani N et al. |
Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages. |
1996 |
Biochim. Biophys. Acta |
pmid:8908154
|
Roullet JB et al. |
Farnesyl analogues inhibit vasoconstriction in animal and human arteries. |
1996 |
J. Clin. Invest. |
pmid:8636420
|
Nozawa Y et al. |
Stachybotrin C and parvisporin, novel neuritogenic compounds. II. Structure determination. |
1997 |
J. Antibiot. |
pmid:9315075
|
Saisho Y et al. |
Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. |
1997 |
Anal. Biochem. |
pmid:9324945
|
Gana-Weisz M et al. |
The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9367867
|
Ghosh PM et al. |
Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. |
1997 |
Biochim. Biophys. Acta |
pmid:9398081
|
Zhang L et al. |
Isolation and characterization of a prenylcysteine lyase from bovine brain. |
1997 |
J. Biol. Chem. |
pmid:9287348
|
Andres DA et al. |
Expression cloning of a novel farnesylated protein, RDJ2, encoding a DnaJ protein homologue. |
1997 |
Arch. Biochem. Biophys. |
pmid:9328291
|